Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Validation of the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaires (BRAFs)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Influence of low socioeconomic status on mortality in granulomatosis with polyangiitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Lymphopenia and neutropenia are associated with subsequent incident proteinuria in Danish patients with systemic lupus erythematosus

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Objective: The aim was to explore dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as an early marker of therapeutic response in patients with rheumatoid arthritis (RA) starting treatment with certolizumab pegol (CZP).Method: In 40 RA patients initiating CZP (27 patients) or 2 weeks of placebo (PCB) followed by CZP (13 patients), DCE-MRI of the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints was performed at weeks 0, 1, 2, 4, 8, and 16. Using semi-automated software, three methods for drawing volume regions of interest (ROIs) in MCP2-5 and PIP2-5 were applied: 'Standard' (slices: all; joints: MCP2-5 together and PIP2-5 together), 'Detailed' (slices: slices with high-quality visualization; joints: as Standard), and 'Single-joint' (slices: as Detailed; joints: each joint separately). The number of enhancing voxels (Nvoxel), initial rate of enhancement (IRE), and maximum enhancement (ME) were extracted and analysed for each method.Results: Nvoxel in MCP2-5, and IRE and ME in PIP2-5 decreased statistically significantly (Wilcoxon rank-sum test, p < 0.02-0.03) after 16 weeks of treatment for the Standard method. Nvoxel and ME decreased significantly more in the CZP group than in the PCB group after 1 week of treatment, but not at later time-points. There were no significant changes for DCE-MRI parameters for the Detailed and Single-joint methods.Conclusions: Certain DCE-MRI parameters detected decreased inflammation during CZP treatment in RA patients. Using specific criteria for ROIs, as in the Detailed and Single-joint methods, decreased the statistical power and could not show any changes over time.

Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume49
Issue number2
Pages (from-to)105-111
Number of pages7
ISSN0300-9742
DOIs
Publication statusPublished - Mar 2020

Bibliographical note

COPECARE

    Research areas

  • Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/diagnostic imaging, Certolizumab Pegol/therapeutic use, Contrast Media, Double-Blind Method, Humans, Image Enhancement, Magnetic Resonance Imaging/methods, Outcome Assessment, Health Care

ID: 61959802